BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34914854)

  • 1. T7 Phage as an Emerging Nanobiomaterial with Genetically Tunable Target Specificity.
    Yue H; Li Y; Yang M; Mao C
    Adv Sci (Weinh); 2022 Feb; 9(4):e2103645. PubMed ID: 34914854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering T7 bacteriophage as a potential DNA vaccine targeting delivery vector.
    Xu H; Bao X; Wang Y; Xu Y; Deng B; Lu Y; Hou J
    Virol J; 2018 Mar; 15(1):49. PubMed ID: 29558962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of Leaderless-Bacteriocin-Producing Bacteriophage Targeting E. coli and Neighboring Gram-Positive Pathogens.
    Masuda Y; Kawabata S; Uedoi T; Honjoh KI; Miyamoto T
    Microbiol Spectr; 2021 Sep; 9(1):e0014121. PubMed ID: 34259542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage T7 as a Potential Platform for Vaccine Development.
    Wong CL; Yong CY; Lee KW
    Methods Mol Biol; 2022; 2412():75-93. PubMed ID: 34918242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the T7 phage display system (Review).
    Deng X; Wang L; You X; Dai P; Zeng Y
    Mol Med Rep; 2018 Jan; 17(1):714-720. PubMed ID: 29115536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in T7 phage application in diagnosis and treatment of various diseases.
    Yu T; Sun Z; Cao X; Pang Q; Deng H
    Int Immunopharmacol; 2022 Sep; 110():109071. PubMed ID: 35978521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the functional landscape of the receptor binding domain of T7 bacteriophage by deep mutational scanning.
    Huss P; Meger A; Leander M; Nishikawa K; Raman S
    Elife; 2021 Mar; 10():. PubMed ID: 33687327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional display of Bacillus thuringiensis Cry1Ac toxin on T7 phage.
    Pacheco S; Gómez I; Sato R; Bravo A; Soberón M
    J Invertebr Pathol; 2006 May; 92(1):45-9. PubMed ID: 16603180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomics-Driven Characterization of LUZ100, a T7-like Pseudomonas Phage with Temperate Features.
    Putzeys L; Poppeliers J; Boon M; Lood C; Vallino M; Lavigne R
    mSystems; 2023 Apr; 8(2):e0118922. PubMed ID: 36794936
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
    Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
    Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage as a Genetically Modifiable Supramacromolecule in Chemistry, Materials and Medicine.
    Cao B; Yang M; Mao C
    Acc Chem Res; 2016 Jun; 49(6):1111-20. PubMed ID: 27153341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Editing of Phage Genomes - Recombineering-Assisted SpCas9 Modification of Model Coliphages T7, T5, and T3].
    Isaev A; Andriianov A; Znobishcheva E; Zorin E; Morozova N; Severinov K
    Mol Biol (Mosk); 2022; 56(6):883. PubMed ID: 36475474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target-specific copper hybrid T7 phage particles.
    Dasa SS; Jin Q; Chen CT; Chen L
    Langmuir; 2012 Dec; 28(50):17372-80. PubMed ID: 23163406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses.
    Shukla GS; Sun YJ; Pero SC; Sholler GS; Krag DN
    J Immunol Methods; 2018 Sep; 460():51-62. PubMed ID: 29906453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage & phosphatase: a novel phage-based probe for rapid, multi-platform detection of bacteria.
    Alcaine SD; Pacitto D; Sela DA; Nugen SR
    Analyst; 2015 Nov; 140(22):7629-36. PubMed ID: 26421320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 12-residue epitope displayed on phage T7 reacts strongly with antibodies against foot-and-mouth disease virus.
    Wong CL; Yong CY; Muhamad A; Syahir A; Omar AR; Sieo CC; Tan WS
    Appl Microbiol Biotechnol; 2018 May; 102(9):4131-4142. PubMed ID: 29564523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of M13 and T7 bacteriophages by TaqMan and SYBR green qPCR.
    Peng X; Nguyen A; Ghosh D
    J Virol Methods; 2018 Feb; 252():100-107. PubMed ID: 29196210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering a Dynamic Controllable Infectivity Switch in Bacteriophage T7.
    Chitboonthavisuk C; Luo CH; Huss P; Fernholz M; Raman S
    ACS Synth Biol; 2022 Jan; 11(1):286-296. PubMed ID: 34985866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interactions of peptides with the innate immune system studied with use of T7 phage peptide display.
    Sokoloff AV; Bock I; Zhang G; Sebestyén MG; Wolff JA
    Mol Ther; 2000 Aug; 2(2):131-9. PubMed ID: 10947940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In utero detection of T7 phage after systemic administration to pregnant mice.
    Srivastava AS; Chauhan DP; Carrier E
    Biotechniques; 2004 Jul; 37(1):81-3. PubMed ID: 15283204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.